# An Ascending Dose Study of BMS-986259 to Study Safety in Healthy Participants

> **NCT04008992** · PHASE1 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 132 (actual)

## Conditions studied

- Healthy Participants

## Interventions

- **DRUG:** BMS-986259
- **OTHER:** Placebo
- **DIAGNOSTIC_TEST:** P-Aminohippurate
- **DIAGNOSTIC_TEST:** Iohexol

## Key facts

- **NCT ID:** NCT04008992
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-06-18
- **Primary completion:** 2021-01-04
- **Final completion:** 2021-01-04
- **Target enrollment:** 132 (ACTUAL)
- **Last updated:** 2021-04-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04008992

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04008992, "An Ascending Dose Study of BMS-986259 to Study Safety in Healthy Participants". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04008992. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*